These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19555896)

  • 1. Protecting children with HIV against pneumococcal disease.
    Meehan A; Mackenzie G; Shingadia D; Booy R
    Lancet Infect Dis; 2009 Jul; 9(7):394-5. PubMed ID: 19555896
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumococcal vaccination in developing countries: where does science end and commerce begin?
    Mathew JL
    Vaccine; 2009 Jul; 27(32):4247-51. PubMed ID: 19389448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox.
    Abzug MJ; Pelton SI
    J Infect Dis; 2009 Apr; 199(8):1109-11. PubMed ID: 19265480
    [No Abstract]   [Full Text] [Related]  

  • 4. Pneumococcal vaccines for children: a global public health priority.
    Pittet LF; Posfay-Barbe KM
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():25-36. PubMed ID: 22862432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.
    Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T
    Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing focus on local epidemiology demonstrates potential value of pneumococcal conjugate vaccines in Middle East and North Africa Region.
    Pelton SI
    Vaccine; 2012 Dec; 30 Suppl 6():G1. PubMed ID: 23228351
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization.
    Cohen AL; Harrison LH; Farley MM; Reingold AL; Hadler J; Schaffner W; Lynfield R; Thomas AR; Campsmith M; Li J; Schuchat A; Moore MR;
    AIDS; 2010 Sep; 24(14):2253-62. PubMed ID: 20671543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of invasive pneumococcal infection in children].
    Sáez-Llorens X
    An Esp Pediatr; 2002 Nov; 57(5):391-3. PubMed ID: 12467540
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges to pneumococcal vaccine in India.
    Kanungo R
    Indian J Med Microbiol; 2013; 31(1):1-2. PubMed ID: 23508420
    [No Abstract]   [Full Text] [Related]  

  • 11. Pneumococcal conjugate vaccine--relevance for developing countries.
    Mulholland K
    Indian Pediatr; 2001 May; 38(5):453-60. PubMed ID: 11359971
    [No Abstract]   [Full Text] [Related]  

  • 12. AAP technical report on the prevention of pneumococcal infections. American Academy of Pediatrics.
    Preboth M
    Am Fam Physician; 2001 Mar; 63(6):1223-4, 1229-30, 1232. PubMed ID: 11277556
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children.
    Paradiso PR
    Clin Infect Dis; 2011 May; 52(10):1241-7. PubMed ID: 21507921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghana and Rwanda expand national immunization programs.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Jul; 8(7):848. PubMed ID: 23213664
    [No Abstract]   [Full Text] [Related]  

  • 15. Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine infant pneumococcal immunization.
    Nzenze SA; Shiri T; Nunes MC; Klugman KP; Kahn K; Twine R; de Gouveia L; von Gottberg A; Madhi SA
    Pediatr Infect Dis J; 2013 Nov; 32(11):1270-8. PubMed ID: 24061271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005.
    Bjornson G; Scheifele DW; Bettinger J; Patrick DM; Gustafson L; Daly P; Tyrrell GJ
    Pediatr Infect Dis J; 2007 Jun; 26(6):540-2. PubMed ID: 17529875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health.
    Kyaw MH; Jones IG; Campbell H
    Acta Paediatr; 2001 May; 90(5):473-6. PubMed ID: 11430703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal nasopharyngeal carriage among infants born to human immunodeficiency virus-infected mothers immunized with pneumococcal polysaccharide vaccine during gestation.
    Almeida Vde C; Negrini BV; Cervi MC; Isaac Mde L; Mussi-Pinhata MM
    Pediatr Infect Dis J; 2011 Jun; 30(6):466-70. PubMed ID: 21200361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with pneumococcal conjugate vaccine in Norway.
    Aaberge IS
    Expert Rev Vaccines; 2009 Feb; 8(2):159-65. PubMed ID: 19196196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What do the next 100 years hold for pneumococcal vaccination?
    Rijkers GT; van Mens SP; van Velzen-Blad H
    Expert Rev Vaccines; 2010 Nov; 9(11):1241-4. PubMed ID: 21087102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.